Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| Giant Renal Cell Carcinoma (RCC): A Case Report of Delayed Diagnosis and Management. | Cureus | 2023 | 37614267 | PubTator, text mining | PubMed |
| The dynamic process of covalent and non-covalent PARylation in the maintenance of genome integrity: a focus on PARP inhibitors. | NAR Cancer | 2023 | 37609662 | PubTator, text mining | PubMed |
| Targeted Protein Degradation: Advances, Challenges, and Prospects for Computational Methods. | J Chem Inf Model | 2023 | 37602861 | PubTator, text mining | PubMed |
| Next-generation bromodomain inhibitors of the SWI/SNF complex enhance DNA damage and cell death in glioblastoma. | J Cell Mol Med | 2023 | 37593885 | PubTator, text mining | PubMed |
| Systematic analysis of histone acetylation regulators across human cancers. | BMC Cancer | 2023 | 37553641 | PubTator, text mining | PubMed |
| Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma. | Front Oncol | 2023 | 37546394 | PubTator, text mining | PubMed |
| Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors. | Biochem Pharmacol | 2023 | 37541451 | PubTator, text mining | PubMed |
| Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer. | Cancer Cell | 2023 | 37541244 | PubTator, text mining | PubMed |
| FOXP1 orchestrates neurogenesis in human cortical basal radial glial cells. | PLoS Biol | 2023 | 37540706 | PubTator, text mining | PubMed |
| Establishment and characterization of a novel cell line (SCCOHT-CH-1) and PDX models derived from Chinese patients of small cell ovarian carcinoma of the hypercalcemic type. | Hum Cell | 2023 | 37535222 | PubTator, text mining | PubMed |
| Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor Activity. | J Med Chem | 2023 | 37523716 | PubTator, text mining | PubMed |
| Differential Contributions of mSWI/SNF Chromatin Remodeler Sub-Families to Myoblast Differentiation. | Int J Mol Sci | 2023 | 37511016 | PubTator, text mining | PubMed |
| Landscape of mSWI/SNF chromatin remodeling complex perturbations in neurodevelopmental disorders. | Nat Genet | 2023 | 37500730 | PubTator, text mining | PubMed |
| Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer. | Int J Biol Sci | 2023 | 37496997 | PubTator, text mining | PubMed |
| Collateral lethality between HDAC1 and HDAC2 exploits cancer-specific NuRD complex vulnerabilities. | Nat Struct Mol Biol | 2023 | 37488358 | PubTator, text mining | PubMed |
| A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer. | Mol Cancer Ther | 2023 | 37486978 | PubTator, text mining | PubMed |
| Regulation of the Wnt signaling pathway during myogenesis by the mammalian SWI/SNF ATPase BRG1. | Front Cell Dev Biol | 2023 | 37484913 | PubTator, text mining | PubMed |
| Baf155 regulates skeletal muscle metabolism via HIF-1a signaling. | PLoS Biol | 2023 | 37478146 | PubTator, text mining | PubMed |
| Salivary glands adenoid cystic carcinoma: a molecular profile update and potential implications. | Front Oncol | 2023 | 37476370 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=18